# OnCo record idea-reg-market-expansion-repricing (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-reg-market-expansion-repricing/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-reg-market-expansion-repricing" ;
  schema:name "Automatic price cuts when a cancer drug's approved indications and volumes expand"@en ;
  schema:description "When a cancer drug is approved for more uses, the company sells far more of it but the price stays the same. Japan cuts prices automatically when sales balloon; others should too."@en ;
  schema:url <https://onco.cc/ideas/idea-reg-market-expansion-repricing/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/nrclinonc.2017.31> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-prasad-nat-rev-clin-oncol/> .
